BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22440870)

  • 1. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
    Lucas J; Zada G
    Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.
    Weinberg BD; Gore A; Shu HG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
    J Am Coll Radiol; 2018 May; 15(5):767-771. PubMed ID: 29503151
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.
    Shah GD; Kesari S; Xu R; Batchelor TT; O'Neill AM; Hochberg FH; Levy B; Bradshaw J; Wen PY
    Neuro Oncol; 2006 Jan; 8(1):38-46. PubMed ID: 16443946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response assessment in neuro-oncology.
    Quant EC; Wen PY
    Curr Oncol Rep; 2011 Feb; 13(1):50-6. PubMed ID: 21086192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttreatment Evaluation of Brain Gliomas.
    Dalesandro MF; Andre JB
    Neuroimaging Clin N Am; 2016 Nov; 26(4):581-599. PubMed ID: 27712795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
    Wen PY; Macdonald DR; Reardon DA; Cloughesy TF; Sorensen AG; Galanis E; Degroot J; Wick W; Gilbert MR; Lassman AB; Tsien C; Mikkelsen T; Wong ET; Chamberlain MC; Stupp R; Lamborn KR; Vogelbaum MA; van den Bent MJ; Chang SM
    J Clin Oncol; 2010 Apr; 28(11):1963-72. PubMed ID: 20231676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
    Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
    Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis?
    Caroline I; Rosenthal MA
    J Clin Neurosci; 2012 May; 19(5):633-7. PubMed ID: 22321359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.
    Kim MM; Lawrence TS; Cao Y
    Semin Radiat Oncol; 2015 Jul; 25(3):172-80. PubMed ID: 26050587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response assessment challenges in clinical trials of gliomas.
    Wen PY; Norden AD; Drappatz J; Quant E
    Curr Oncol Rep; 2010 Jan; 12(1):68-75. PubMed ID: 20425610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of adult glioma is multiphasic].
    Mäenpää HO
    Duodecim; 2010; 126(14):1669-75. PubMed ID: 20804085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Growth patterns of recurrent tumors].
    Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
    Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1073-80. PubMed ID: 2466210
    [No Abstract]   [Full Text] [Related]  

  • 13. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound.
    Schneider CS; Woodworth GF; Vujaskovic Z; Mishra MV
    Radiother Oncol; 2020 Jan; 142():43-51. PubMed ID: 31431370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI.
    Fatterpekar GM; Galheigo D; Narayana A; Johnson G; Knopp E
    AJR Am J Roentgenol; 2012 Jan; 198(1):19-26. PubMed ID: 22194475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Stupp R; Roila F;
    Ann Oncol; 2008 May; 19 Suppl 2():ii83-5. PubMed ID: 18456781
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain stem gliomas: therapeutic options at time of recurrence.
    Rekate HL
    Pediatr Neurosurg; 1996 Oct; 25(4):220. PubMed ID: 9293549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of treatment results in glioma using computed tomography].
    Kruminia GA
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (6):12-20. PubMed ID: 3239304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.
    Shapiro LQ; Beal K; Goenka A; Karimi S; Iwamoto FM; Yamada Y; Zhang Z; Lassman AB; Abrey LE; Gutin PH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):636-42. PubMed ID: 22765876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.